RecallDepth
Class II Terminated

Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.

This recall has been terminated (originally issued December 17, 2014).

Company
Pfizer Inc.
Recall Initiated
December 3, 2014
Posted
December 17, 2014
Recall Number
D-0292-2015
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
31,569 HDPE Bottles
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.

Distribution

Pfizer shipped the affected product to 4,447 direct accounts. No federal government accounts received the affected product directly from Pfizer Inc.

Lot / Code Info

Lot # a) H79652, Exp. 10/15; b) H79653, Exp. 10/15

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls